In this regard, elevated levels of Plasminogen Activator Inhibitor-1 (PAI-1) have been reported to play a key role in COVID-19-associated coagulopathy, and its targeting have therapeutic benefits in COVID-19 (44). Here, SERPINE1 is linked to blood coagulation disease.